News | May 28, 2025
Fluor-built Bayer cell therapy facility in California achieves LEED v4 platinum certification
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Akums invested Rs. 272 crore in capital expenditure during FY25
R&D spend for Q4 was Rs. 50.3 crore, 4.9 per cent of Q4?revenue
The company recorded its quarterly consolidated revenue from operations at Rs. 61.22 crore in Q4 FY25
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Sun Pharma will invest up to $25 million in US-based Pharmazz Inc, raising its stake to 22.7%
Allopurinol is used to prevent or lower high uric acid levels in the blood
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
Subscribe To Our Newsletter & Stay Updated
